Relative lower body weight, hyperglycemia, glucose intolerance, and dramatically increased sensitivity to STZ treatment in HDAC3 KO mice strongly suggest a developmental and/or functional defect in pancreatic islet β-cells. Here, HDAC3 is linked to Glucose intolerance.